MacroGenics
MGNX
#9332
Rank
NZ$0.27 B
Marketcap
NZ$4.26
Share price
0.84%
Change (1 day)
47.47%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.27 Billion

As of October 2026 MacroGenics has a market cap of NZ$0.27 Billion. This makes MacroGenics the world's 9332th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.27 B54.35%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Oct 30th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.27 Billion
by Nasdaq info icon info icon
NZ$0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$308.83 B 113,684.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.241 T 825,817.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$447.29 B 164,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$376.05 B 138,448.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$654.92 B 241,194.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$226.74 B 83,438.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.93 B 1,350.30%๐Ÿ‡บ๐Ÿ‡ธ USA